HBM Holdings Limited (HKG:2142)
Hong Kong · Delayed Price · Currency is HKD 13.21
+0.15 (1.15%)
Oct 30, 2025, 4:08 PM HKT
HBM Holdings Market Cap
HBM Holdings has a market cap or net worth of 10.95 billion as of October 30, 2025. Its market cap has increased by 979.29% in one year.
Market Cap
10.95B
Enterprise Value
8.94B
Revenue
908.35M
Ranking
n/a
PE Ratio
18.06
Stock Price
13.21
Market Cap Chart
Since December 10, 2020, HBM Holdings's market cap has increased from 8.46B to 10.95B, an increase of 29.37%. That is a compound annual growth rate of 5.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 11.07B | 712.72% |
| Dec 31, 2024 | 1.36B | -3.91% |
| Dec 29, 2023 | 1.42B | -32.16% |
| Dec 30, 2022 | 2.09B | -63.14% |
| Dec 31, 2021 | 5.67B | -30.06% |
| Dec 31, 2020 | 8.11B | -4.17% |
| Dec 10, 2020 | 8.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 271.02B |
| Hansoh Pharmaceutical Group Company | 209.22B |
| JD Health International | 199.13B |
| WuXi Biologics | 149.43B |
| Innovent Biologics | 144.96B |
| Sino Biopharmaceutical | 125.85B |
| Akeso | 105.01B |
| Sichuan Kelun-Biotech Biopharmaceutical | 98.36B |